Doxepin Hydrochloride Patent Expiration
Doxepin Hydrochloride is Used for treating insomnia. It was first introduced by Pfizer Laboratories Div Pfizer Inc
Doxepin Hydrochloride Patents
Given below is the list of patents protecting Doxepin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Silenor | US10238620 | Methods of using low-dose doxepin for the improvement of sleep | May 18, 2027 | Currax |
| Silenor | US10548871 | Low-dose doxepin formulations and methods of making and using the same | Apr 11, 2028 | Currax |
| Silenor | US10653660 | Methods of improving the pharmacokinetics of doxepin | Jul 20, 2027 | Currax |
| Silenor | US10653662 | Methods of using low-dose doxepin for the improvement of sleep | May 18, 2027 | Currax |
| Silenor | US11096920 | Low-dose doxepin formulations and methods of making and using the same | Apr 11, 2028 | Currax |
| Silenor | US11110074 | Methods of improving the pharmacokinetics of doxepin | Jul 20, 2027 | Currax |
| Silenor | US11234954 | Low-dose doxepin for treatment of sleep disorders in elderly patients | Jan 18, 2028 | Currax |
| Silenor | US5502047 | Treatment for insomnia |
Mar 26, 2013
(Expired) | Currax |
| Silenor | US5585115 | Pharmaceutical excipient having improved compressability |
Jan 09, 2015
(Expired) | Currax |
| Silenor | US5725884 | Pharmaceutical excipient having improved compressibility |
Jan 09, 2015
(Expired) | Currax |
| Silenor | US5866166 | Pharmaceutical excipient having improved compressibility |
Jan 09, 2015
(Expired) | Currax |
| Silenor | US5948438 | Pharmaceutical formulations having improved disintegration and/or absorptivity |
Jan 09, 2015
(Expired) | Currax |
| Silenor | US6103219 | Pharmaceutical excipient having improved compressibility |
Jan 09, 2015
(Expired) | Currax |
| Silenor | US6211229 | Treatment of transient and short term insomnia |
Feb 17, 2020
(Expired) | Currax |
| Silenor | US6217909 | Pharmaceutical excipient having improved compressibility |
Jan 09, 2015
(Expired) | Currax |
| Silenor | US7915307 | Methods of improving the pharmacokinetics of doxepin | Aug 24, 2027 | Currax |
| Silenor | US8513299 | Methods of using low-dose doxepin for the improvement of sleep | Sep 07, 2030 | Currax |
| Silenor | US9107898 | Methods of using low-dose doxepin for the improvement of sleep | May 01, 2028 | Currax |
| Silenor | US9486437 | Methods of using low-dose doxepin for the improvement of sleep | May 18, 2027 | Currax |
| Silenor | US9532971 | Low-dose doxepin formulations and methods of making and using the same | Jun 01, 2029 | Currax |
| Silenor | US9572814 | Methods of improving the pharmacokinetics of doxepin | Jul 20, 2027 | Currax |
| Silenor | US9861607 | Methods of using low-dose doxepin for the improvement of sleep | May 18, 2027 | Currax |
| Silenor | US9907780 | Low-dose doxepin formulations and methods of making and using the same | Apr 11, 2028 | Currax |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Doxepin Hydrochloride's patents.
Latest Legal Activities on Doxepin Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Doxepin Hydrochloride.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 19 Jun, 2024 | US9532971 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 24 Apr, 2024 | US9486437 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 01 Nov, 2023 | US10653660 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 01 Nov, 2023 | US10653662 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 19 Jul, 2023 | US10548871 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 01 Feb, 2023 | US9107898 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 14 Sep, 2022 | US10238620 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 14 Sep, 2022 | US7915307(Litigated) |
| Patent Issue Date Used in PTA Calculation | 01 Feb, 2022 | US11234954 |
| Recordation of Patent Grant Mailed | 01 Feb, 2022 | US11234954 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Doxepin Hydrochloride Generics
Several generic applications have been filed for Doxepin Hydrochloride. The first generic version for Doxepin Hydrochloride was by Mylan Pharmaceuticals Inc and was approved on May 13, 1986. And the latest generic version is by Ajanta Pharma Ltd and was approved on Jul 1, 2024.
Given below is the list of companies who have filed for Doxepin Hydrochloride generic.
1. TARO
Taro Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Jul 1, 2020 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Jul 1, 2020 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Jul 1, 2020 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Jul 1, 2020 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Jul 1, 2020 |
2. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | cream | Prescription | TOPICAL | AB | Aug 16, 2023 |
3. PHARM ASSOC
Pharmaceutical Assoc Inc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharm Assoc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE/ML | concentrate | Discontinued | ORAL | N/A | Jan 15, 2004 |
4. MICRO LABS
Micro Labs Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Jun 27, 2023 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Jun 27, 2023 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Jun 27, 2023 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Jun 27, 2023 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Jun 27, 2023 |
5. LANNETT CO INC
Lannett Co Inc has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE/ML
(reference standard) | concentrate | Prescription | ORAL | N/A | Dec 29, 1998 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Jul 24, 2020 |
| EQ 25MG BASE | capsule | Discontinued | ORAL | N/A | Jul 24, 2020 |
| EQ 10MG BASE | capsule | Discontinued | ORAL | N/A | Jul 24, 2020 |
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Jul 24, 2020 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Jul 24, 2020 |
6. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6MG BASE | tablet | Prescription | ORAL | AB | Jul 24, 2020 |
| EQ 3MG BASE | tablet | Prescription | ORAL | AB | Jul 24, 2020 |
7. MSN
Msn Laboratories Private Ltd has filed for 7 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Msn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Jun 24, 2022 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Jun 24, 2022 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Jun 24, 2022 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Jun 24, 2022 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Jun 24, 2022 |
| EQ 6MG BASE | tablet | Prescription | ORAL | AB | Apr 3, 2023 |
| EQ 3MG BASE | tablet | Prescription | ORAL | AB | Apr 3, 2023 |
8. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Apr 21, 2021 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Apr 21, 2021 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Apr 21, 2021 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Apr 21, 2021 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Apr 21, 2021 |
9. WATSON LABS
Watson Laboratories Inc has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | capsule | Discontinued | ORAL | N/A | Mar 29, 1991 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Apr 30, 1987 |
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Apr 30, 1987 |
| EQ 10MG BASE | capsule | Discontinued | ORAL | N/A | Mar 29, 1991 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Feb 9, 1988 |
| EQ 150MG BASE | capsule | Discontinued | ORAL | N/A | Feb 9, 1988 |
10. QUANTUM PHARMICS
Quantum Pharmics Ltd has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Quantum Pharmics.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | capsule | Discontinued | ORAL | N/A | Sep 29, 1987 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Sep 29, 1987 |
| EQ 25MG BASE | capsule | Discontinued | ORAL | N/A | Sep 29, 1987 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Sep 29, 1987 |
| EQ 150MG BASE | capsule | Discontinued | ORAL | N/A | Mar 15, 1989 |
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Mar 15, 1989 |
11. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 8 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | capsule | Prescription | ORAL | AB | Mar 21, 2023 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Mar 23, 2023 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Mar 23, 2023 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Mar 23, 2023 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Mar 23, 2023 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Mar 23, 2023 |
| EQ 6MG BASE | tablet | Discontinued | ORAL | N/A | Aug 16, 2023 |
| EQ 3MG BASE | tablet | Discontinued | ORAL | N/A | Aug 16, 2023 |
12. PUREPAC PHARM
Purepac Pharmaceutical Co has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Purepac Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Sep 8, 1988 |
| EQ 150MG BASE | capsule | Discontinued | ORAL | N/A | Sep 8, 1988 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Sep 8, 1988 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Dec 28, 1990 |
| EQ 25MG BASE | capsule | Discontinued | ORAL | N/A | Dec 28, 1990 |
| EQ 10MG BASE | capsule | Discontinued | ORAL | N/A | Dec 28, 1990 |
13. AMNEAL PHARMS CO
Amneal Pharmaceuticals Co Gmbh has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Jun 28, 2017 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Jun 28, 2017 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Jun 28, 2017 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Jun 28, 2017 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Jun 28, 2017 |
14. RK PHARMA
Rk Pharma Inc has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Rk Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE | tablet | Prescription | ORAL | AB | Jan 20, 2016 |
| EQ 6MG BASE | tablet | Prescription | ORAL | AB | Jan 20, 2016 |
15. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3MG BASE | tablet | Prescription | ORAL | AB | Jul 26, 2013 |
| EQ 6MG BASE | tablet | Prescription | ORAL | AB | Jul 26, 2013 |
16. LEADING
Leading Pharma Llc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Leading.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | capsule | Prescription | ORAL | AB | Mar 1, 2021 |
17. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Sep 4, 2020 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Sep 4, 2020 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Sep 4, 2020 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Sep 4, 2020 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Sep 4, 2020 |
18. SANDOZ
Sandoz Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | May 15, 1986 |
| EQ 25MG BASE | capsule | Discontinued | ORAL | N/A | May 15, 1986 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | May 15, 1986 |
| EQ 10MG BASE | capsule | Discontinued | ORAL | N/A | Mar 2, 1987 |
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Mar 2, 1987 |
19. EDENBRIDGE PHARMS
Edenbridge Pharmaceuticals Llc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Edenbridge Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | capsule | Prescription | ORAL | AB | Apr 19, 2022 |
20. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 7 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Sep 13, 2019 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Sep 13, 2019 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Sep 13, 2019 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Sep 13, 2019 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Sep 13, 2019 |
| EQ 6MG BASE | tablet | Prescription | ORAL | AB | Jul 1, 2024 |
| EQ 3MG BASE | tablet | Prescription | ORAL | AB | Jul 1, 2024 |
21. CONTRACT PHARMACAL
Contract Pharmacal Corp has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Contract Pharmacal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Jul 28, 2020 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Jul 28, 2020 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Jul 28, 2020 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Jul 28, 2020 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Jul 28, 2020 |
22. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | capsule | Discontinued | ORAL | N/A | Feb 18, 1988 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Feb 18, 1988 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Feb 18, 1988 |
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Feb 18, 1988 |
23. UNIQUE PHARM
Unique Pharmaceutical Laboratories has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Unique Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Aug 21, 2023 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Aug 21, 2023 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Aug 21, 2023 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Aug 21, 2023 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Aug 21, 2023 |
24. JUBILANT CADISTA
Jubilant Cadista Pharmaceuticals Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Jubilant Cadista.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Mar 14, 2022 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Mar 14, 2022 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Mar 14, 2022 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Mar 14, 2022 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Mar 14, 2022 |
25. DAVA PHARMS INC
Dava Pharmaceuticals Inc has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Dava Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Jan 5, 1988 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Jan 5, 1988 |
| EQ 25MG BASE | capsule | Discontinued | ORAL | N/A | Jan 5, 1988 |
| EQ 10MG BASE | capsule | Discontinued | ORAL | N/A | Jan 5, 1988 |
| EQ 150MG BASE | capsule | Discontinued | ORAL | N/A | Jan 5, 1988 |
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Jan 5, 1988 |
26. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | May 13, 1986 |
| EQ 25MG BASE
(reference standard) | capsule | Prescription | ORAL | AB | May 13, 1986 |
| EQ 100MG BASE
(reference standard) | capsule | Prescription | ORAL | AB | May 13, 1986 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | May 13, 1986 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | May 13, 1986 |
27. APPCO
Appco Pharma Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Appco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Apr 1, 2021 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Apr 1, 2021 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Apr 1, 2021 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Apr 1, 2021 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Apr 1, 2021 |
28. TEVA PHARMS
Teva Pharmaceuticals Development Inc has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE/ML | concentrate | Discontinued | ORAL | N/A | Nov 9, 1987 |
| 5% | cream | Prescription | TOPICAL | AB | Feb 17, 2023 |
29. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Mar 27, 2019 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Mar 27, 2019 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Mar 27, 2019 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Mar 27, 2019 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Mar 27, 2019 |
30. CHEMISTRY HLTH
Chemistry And Health Fz Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Chemistry Hlth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Mar 9, 2021 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Mar 9, 2021 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Mar 9, 2021 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Mar 9, 2021 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Mar 9, 2021 |
31. ENDO OPERATIONS
Endo Operations Ltd has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Nov 9, 1987 |
| EQ 10MG BASE | capsule | Discontinued | ORAL | N/A | Nov 9, 1987 |
| EQ 25MG BASE | capsule | Discontinued | ORAL | N/A | Nov 9, 1987 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Nov 9, 1987 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Nov 9, 1987 |
| EQ 150MG BASE
(reference standard) | capsule | Prescription | ORAL | AB | Nov 9, 1987 |
32. EPIC PHARMA LLC
Epic Pharma Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Oct 16, 2020 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Oct 16, 2020 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Oct 16, 2020 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Mar 3, 2022 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Mar 3, 2022 |
33. MANKIND PHARMA
Mankind Pharma Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Feb 9, 2022 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Feb 9, 2022 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Feb 9, 2022 |
| EQ 10MG BASE | capsule | Prescription | ORAL | AB | Feb 9, 2022 |
| EQ 25MG BASE | capsule | Prescription | ORAL | AB | Feb 9, 2022 |
34. PAR PHARM
Par Pharmaceutical Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Par Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE | capsule | Discontinued | ORAL | N/A | Nov 9, 1987 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Nov 9, 1987 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Nov 9, 1987 |
| EQ 150MG BASE | capsule | Prescription | ORAL | N/A | Nov 9, 1987 |
| EQ 10MG BASE | capsule | Discontinued | ORAL | N/A | Nov 9, 1987 |
35. PHARMOBEDIENT CNSLTG
Pharmobedient Consulting has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE/ML | concentrate | Discontinued | ORAL | N/A | Jul 20, 1988 |
36. WATSON LABS TEVA
Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Mar 29, 1991 |